Skip to content
  • Home
  • Stocks
    • Large-Cap
    • S&P 500
    • Mid-Cap
    • Small-Cap
    • Foreign
    • micro cap stocks
    • Industries
    • IPOs
  • Crypto
    • Bitcoin Hub
    • Ethereum Hub
    • Comparisons
    • Safety
  • ETFs
  • Blog
  • Privacy Policy
  • Home
  • Stocks
    • Large-Cap
    • S&P 500
    • Mid-Cap
    • Small-Cap
    • Foreign
    • micro cap stocks
    • Industries
    • IPOs
  • Crypto
    • Bitcoin Hub
    • Ethereum Hub
    • Comparisons
    • Safety
  • ETFs
  • Blog
  • Privacy Policy

Company Name: TrovaGene, Inc

February 16, 2025 by Shak

Company Name: TrovaGene, Inc. 

TrovaGene, Inc. designs technology that is used to monitor cancer.  The company’s Precision Cancer Monitoringsm platform is designed to be a non-invasive way to measure cancer causing DNA mutations in urine and blood.

Ticker Symbol: TROV (NASDAQ)

Company Website: www.trovagene.com

Social Media:

TrovaGene Facebook

TrovaGene LinkedIn Page

TrovaGene Twitter

Headquarters: San Diego, California

Publicly Traded Companies by Sector and Industry

List of Publicly Traded Healthcare Companies

List of Large-Cap Biotech Stocks

List of Mid-Cap Biotech Stocks

List of Small-Cap Biotech Stocks

List of Micro-Cap Biotech Stocks

List of Large-Cap Pharmaceutical Stocks

List of Mid-Cap Pharmaceutical Stocks

List of Small-Cap Pharmaceutical Stocks

List of Micro-Cap Pharmaceutical Stocks
 

List of Large-Cap Medical Device Stocks

List of Mid-Cap Medical Device Stocks

List of Small-Cap Medical Device Stocks

List of Micro-Cap Medical Device Stocks

Categories Blog
Company Name: Dicerna Pharmaceuticals, Inc.
iShares Core Short-Term USD Bond ETF

Providing data-driven insights for smart investing in public markets, crypto, and ETFs.

Facebook Twitter Youtube Linkedin

Quick Links

Stocks

Crypto

ETFs

Tools

Quick Links

Learn

News & Insights

About Us

Contact

Partners

Quick Links

Privacy Policy

Terms of Service

Disclaimer

Disclosures

Data Sources

Informational only, not financial advice.

© 2025 InvestSnips. All rights reserved